Kontrol Technologies Corp N.KNR

Alternate Symbol(s): KNRLF

Utilities Software - Application Utilities - Independent Power Producers

Kontrol Technologies Corp. is a provider of energy management, continuous air quality and emission solutions to commercial and industrial consumers. It delivers building intelligence through the Internet of things (IoT), software and cloud technology as well as project integration. Its smart technology is deployed to customers through a cloud-based interface accessible on desktops and mobile devices. It collects real-time and historical data using IoT sensors and direct connection to industrial control systems, bringing various sources of asset performance data into the cloud where smart-learning software is applied to optimize performance. The Company, through CEM Specialties Inc., offers turn-key emission monitoring equipment, integration design, manufacturing, service, repairs, and on-site performance certification testing. It offers building heating, ventilation, and air conditioning integration, automation and retrofits to enhance the energy efficiency of buildings and facilities.

NEO:KNR - Post by User

Kontrol Technologies Corp

Bullboard Posts

Comment by Qrewpton Oct 07, 2020 12:32am

311 Views

Post# 31678636

RE:RE:RE:RE:RE:RE:RE:Are you skeptical about Biocloud?

I don't think that's the correct interpretation of KNR's statements. KNR news releases state that they need to "establish lower detection limits" which to me mean to define the sensitivity of the the device, room requirements, etc. Specifications they would certify and publish in a datasheet.
The Ceo has set firm milestones, CSA approval this month, ready to ship in November. So far they have met all publicly announced commitments in developing this product.
In a recent interview, the ceo used a smoke detector as a metaphor for how the Biocloud could manage sensitivity, I recommend a listen, I can't remember which interview it was though. It doesn't sound like sensitivity level is an issue. This stock doesn't have firm sales of Biocloud yet, so technically it is a bit of Spec, but let's be real, there are plenty of indications that suggest this is going to work, and if it does it's going to be multiple times higher than it is today, so you're compensated for the risk. If you wait for all the announcements to be made you'll miss the boat. The catalyst occurs between now and november, it's not like they're promising a fusion reactor by 2035. Also, they have an existing core growing business that's doing almost $15m of revenue, which on its own is worth $30 to 60 million, so there is some downside protection too.

ArnoldLayne wrote: They need to lower the detection limit to make it commercialy feasible. Still a spec play at this point
DD34 wrote: Once the market has the validation that the product will sell this will be revalued quickly. There is company interest in uplisting to a better exchange as well during that time. This is all in my opinion and as a newer investor you shouldn't believe much of what you hear on a stock chat board ;)
Jefflauraemma03 wrote: DD34, when you say, "scream straight up for a week straight"....cab you be more specific?

I am new to the trading world and am doing my best to get any info to help grow my portfolio and cash flow.

Any help would be greatly appreciated